Illustrative image – not actual.Teva Pharmaceutical Industries (TPI), Israel is planning to venture in India through a JV with US based Proctor & Gamble (P&G).
The JV - P&G Teva - will set up an over-the-counter (OTC) drug manufacturing facility at Sanand with an initial investment of Rs 250 crore. Around 15 acre has already been acquired for the project. The facility will have two separate lines, one for manufacturing Ayurvedic drugs and another for allopathic medicines.
A formal announcement is likely to be made after the signing of an MoU with the state government during the Vibrant Gujarat Global Summit-2013 scheduled for January 2013.
Related Links:
Project profile
Project profile
